Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) is expected to issue its Q2 2026 results after the market closes on Thursday, August 6th. Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) last announced its earnings results on Thursday, May 7th. Get Corvus Pharmaceuticals alerts:Corvus Pharmaceuticals Stock Up 4.1%Shares of NASDAQ CRVS opened at $13.92 on Wednesday. Corvus Pharmaceuticals has a 12-month low of $4.05 and a 12-month high of $26.95. Featured StoriesReceive News & Ratings for Corvus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corvus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.